Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500103999Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of oliceridine in postoperative pain and thoracolumbar fusion (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: I-FEED score. Planned start Jun 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500103999.